van Haren, F. M., Richardson, A., Yoon, H., Artigas, A., Laffey, J. G., Dixon, B., Smith, R., Vilaseca, A. B., Barbera, R. A., Ismail, T. I., Mahrous, R. S., Badr, M., De Nucci, G., Sverdloff, C., van Loon, L. M., Camprubi‐Rimblas, M., Cosgrave, D. W., Smoot, T. L., Staas, S., Sann, K., Sas, C., Belani, A., Hillman, C., Shute, J., Carroll, M., Wilkinson, T., Carroll, M., Singh, D., & Page, C. (2021). iNHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): Protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies. British journal of clinical pharmacology, 87(8), 3075–3091. http://access.bl.uk/ark:/81055/vdc_100135172495.0x00003d